As shown in Additional file 3: Fig. S1a, TET2, RHOA and DNMT3A mutations tended to cluster in AITL and PTCL-NOS patients, while none in ALK + or ALK- ALCL. This evidence concerns the gene DNMT3A and angioimmunoblastic T-cell lymphoma.